CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancerErin M. Bange, John P. Reilly, Nicholas Han et al.|Nature Medicine|2021Cited by 519
Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell LymphomaMichael Wang, Nirav N. Shah, Youngil Koh et al.|Journal of Clinical Oncology|2023Cited by 106
Clinical efficacy and safety of chimeric antigen receptor T‐cell therapy for mantle cell lymphoma with secondary central nervous system involvementChristine E. Ryan, Reid W. Merryman, Rebecca L. Zon et al.|British Journal of Haematology|2023Cited by 16